Moderna (MRNA) Net Income CAGR: History & Chart | TGMCharts
Net Income CAGR: N/A
Based on reported financial statement history.
Over the past 12 months, Net Income CAGR is N/A.The TTM figure compares the trailing 12 months (sum of the latest four quarters) with the 12 months before that. Rows in the history table compare fiscal years, and the quarterly table compares single quarters; the three measure different windows and will differ. Net income CAGR shows how the company's bottom-line profitability has grown. This reflects the company's ability to convert revenue into profits after all expenses.
MRNA Net Income CAGR Chart
No data available
MRNA Quarterly Net Income Growth (YoY)
Net Income growth vs the same fiscal quarter in the prior fiscal year, last 24 comparable quarters.
tgmcharts.com
Net Income
MRNA Quarterly Net Income
$-782.00M
Reported quarterly net income; no daily interpolation. Q2 FY2026 (2026-06-30): $-782.00M.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-09-09T20:00:01.000Z. Historical observations retain their original dates. Historical series through 2023-11-03.
Unrounded diluted TTM EPS / FMP quote price × 100 Quote observation: 2026-09-09T20:00:01.000Z. Historical observations retain their original dates. Historical series through 2023-11-03.
tgmcharts.com
MRNA Net Income CAGR History
Year
Start Net Income
End Net Income
Change
% Change
2025
−$3.56B
−$2.82B
+$739.00M
N/A
2024
−$4.71B
−$3.56B
+$1.15B
N/A
2023
$8.36B
−$4.71B
−$13.08B
-156.37%
2022
$12.20B
$8.36B
−$3.84B
-31.47%
2021
−$747.06M
$12.20B
+$12.95B
N/A
2020
−$514.02M
−$747.06M
−$233.04M
N/A
2019
−$384.73M
−$514.02M
−$129.29M
N/A
2018
−$255.92M
−$384.73M
−$128.82M
N/A
2017
−$216.21M
−$255.92M
−$39.70M
N/A
Quarterly Net Income: QoQ & YoY
Period
Period End
Value
QoQ Growth
YoY Growth
Q2 FY2026
2026-06-30
-$782.00M
+41.8%
+5.2%
Q1 FY2026
2026-03-31
-$1.34B
-62.6%
-38.3%
Q4 FY2025
2025-12-31
-$826.00M
-313.0%
+26.3%
Q3 FY2025
2025-09-30
-$200.00M
+75.8%
N/A
Q2 FY2025
2025-06-30
-$825.00M
+15.0%
+35.5%
Q1 FY2025
2025-03-31
-$971.00M
+13.3%
+17.4%
Q4 FY2024
2024-12-31
-$1.12B
N/A
N/A
Q3 FY2024
2024-09-30
$13.00M
N/A
N/A
Q2 FY2024
2024-06-30
-$1.28B
-8.9%
+7.3%
Q1 FY2024
2024-03-31
-$1.18B
N/A
N/A
Q4 FY2023
2023-12-31
$217.00M
N/A
-85.2%
Q3 FY2023
2023-09-30
-$3.63B
-163.0%
N/A
Q2 FY2023
2023-06-30
-$1.38B
N/A
N/A
Q1 FY2023
2023-03-31
$79.00M
-94.6%
-97.8%
Q4 FY2022
2022-12-31
$1.47B
+40.5%
-69.9%
Q3 FY2022
2022-09-30
$1.04B
-52.5%
-68.7%
QoQ Growth compares the previous fiscal quarter; YoY Growth compares the same fiscal quarter in the prior fiscal year. Missing or ambiguous fiscal periods render N/A.